Accessibility Menu
Ensign Group logo

Ensign Group

(NASDAQ) ENSG

Current Price$171.48
Market Cap$10.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)+4,584%
5 Year+99%
1 Year+24%
1 Month+10%
Ensign Group last closing stock price
MetricPriceDate
Last closeUSD 171.282026-07-17
Ensign Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.6%USD 168.592026-07-10
1 month+9.95%USD 155.782026-06-17
3 month-14.37%USD 200.032026-04-17
Year to date-1.6%USD 174.072025-12-31
1 year+23.54%USD 138.652025-07-17
3 year+91.85%USD 89.282023-07-18
5 year+99.09%USD 86.032021-07-16
Since inception+4,584.24%USD 3.662007-11-09

Ensign Group Financials at a Glance

Market Cap

$10.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.27B

Net Income (TTM)

$363.36M

EPS (TTM)

$6.15

P/E Ratio

27.87

Dividend

$0.26

Beta (Volatility)

0.55 (Low)

Price

$171.48

Volume

29,963

Open

$172.06

Previous Close

$171.48

Daily Range

$171.20 - $175.88

52-Week Range

$134.80 - $218.00

Estimated Earnings Date

Jul 23, 2026

ENSG: Motley Fool Moneyball Superscore

82

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ensign Group

Ensign helps seniors and patients recover from illness or injury in specialized care homes. Its facilities provide nursing, therapy, and housing for people who need medical help but do not need a hospital. The company also owns the buildings where these health services are provided.

What Ensign Offers

  • Skilled Services: Nursing care and rehabilitation therapies for patients with chronic conditions or joint replacements; represented 95.6% of revenue for the year ended December 31, 2025.
  • Standard Bearer: Real estate segment that owns and leases healthcare buildings to Ensign and other operators; generated $126.9 million in rental revenues during 2025.
  • Senior Living: Residential housing and daily living support for independent seniors or those needing minor help; contributes roughly 2.2% of annual revenue.
  • Ancillary Services: Mobile medical services like digital x-rays, ultrasounds, and lab tests provided at home or in care centers.

Recent Growth and Expansion

  • Acquired 145 facilities between January 1, 2021 and December 31, 2025, adding over 14,000 skilled nursing beds to the portfolio.
  • Established Standard Bearer Healthcare REIT in January 2022 to manage and grow its portfolio of owned healthcare real estate.
  • Purchased 25 stand-alone skilled nursing properties and two campus operations through Standard Bearer during the 2025 fiscal year.
  • Expanded operations further after December 31, 2025, by adding five additional skilled nursing facilities to the network.

What Makes Ensign Different

Ensign operates with a decentralized structure that empowers local leaders to tailor care to their specific communities. This field-driven approach is supported by a centralized service center that handles back-office tasks like payroll and legal work for all locations.

The Financial Scorecard

  • Revenue reached $1.4 billion in Q4 2025, a 20.2% increase from $1.1 billion in Q4 2024.
  • Net income rose to $95.5 million in Q4 2025, up 19.8% from $79.7 million in Q4 2024.
  • Operating cash flow hit $183.3 million in Q4 2025, an 82.5% jump from $100.5 million in the prior year period.
  • Free cash flow grew to $133.5 million in Q4 2025, up 155.2% from $52.3 million in Q4 2024.

Bottom Line

Ensign has grown from a regional provider into a multi-state healthcare holding company by combining clinical services with a large real estate portfolio. Its strategy focuses on acquiring underperforming facilities and improving their quality and occupancy through a localized leadership model.

AI Generated • Apr 20, 2026

Industry

Healthcare Providers and Services

Employees

46,000

CEO

Barry R. Port, MBA

Headquarters

San Juan Capistrano, CA 92675, US

ENSG Financials

Key Financial Metrics (TTM)

Gross Margin

13.93%

Operating Margin

8.51%

Net Income Margin

6.89%

Return on Equity

16.63%

Return on Capital

6.66%

Return on Assets

6.48%

Earnings Yield

3.59%

Dividend Yield

0.15%

Payout Ratio

4.02%

Stock Overview

Market Cap

$10.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

58.45M

Volume

29.96K

Avg. Volume

830.36K

Financials (TTM)

Gross Profit

$734.87M

Operating Income

$448.79M

EBITDA

$594.44M

Operating Cash Flow

$592.20M

Capital Expenditure

-$186.10M

Free Cash Flow

$406.10M

Cash & ST Invst.

$595.18M

Total Debt

$2.24B

Ensign Group Performance Analysis

Ensign Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,943,631,00015.3%
20232023-12-31USD 3,664,602,00024.5%
20242024-12-31USD 4,260,485,00016.3%
20252025-12-31USD 5,057,841,00018.7%
Ensign Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-304.7%
Q32025-09-305.6%
Q42025-12-315.0%
Q12026-03-312.1%
Ensign Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 3.9515.5%
20232023-12-31USD 3.65-7.5%
20242024-12-31USD 5.1240.1%
20252025-12-31USD 5.8414.2%
Ensign Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-305.1%
Q32025-09-30-1.4%
Q42025-12-3113.4%
Q12026-03-313.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.39B

+18.4%

Gross Profit

$227.86M

+21.1%

Gross Margin

16.40%

N/A

Market Cap

$10.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$217.62K

N/A

Employees

46,000

N/A

Net Income

$99.67M

+24.2%

EBITDA

$159.31M

+20.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$595.18M

+72.8%

Total Debt

$2.24B

+11.7%

Accounts Receivable

$663.25M

+13.6%

Inventory

$0.00

N/A

Long Term Debt

$2.12B

+11.3%

Short Term Debt

$120.76M

+19.2%

Return on Assets

6.48%

N/A

Return on Invested Capital

9.42%

N/A

Free Cash Flow

$64.68M

+120.8%

Operating Cash Flow

$100.15M

+38.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UHSUniversal Health Services, Inc.
$151.16-1.55%
EHCEncompass Health Corporation
$112.21-0.25%
BMRNBioMarin Pharmaceutical Inc.
$59.59-0.68%
QGENQiagen N.V.
$41.15-0.87%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
NFLXNetflix
$68.95-0.07%
INTCIntel
$95.04-0.02%
NOKNokia
$10.12-0.03%

Questions About ENSG

What is the current price of Ensign Group?

Ensign Group is trading at $171.48 per share.

What is the 52-week range for Ensign Group?

Over the past 52 weeks, Ensign Group has traded between $134.80 and $218.00.

How much debt does Ensign Group have?

As of the most recent reporting period, Ensign Group reported total debt of $2.24B.

How much cash does Ensign Group have on hand?

Ensign Group reported $539.50M in cash and cash equivalents in its most recent financial results.

What is Ensign Group’s dividend yield?

Ensign Group currently has a dividend yield of 0.15%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.